1. Home
  2. FTFT vs IMNN Comparison

FTFT vs IMNN Comparison

Compare FTFT & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTFT
  • IMNN
  • Stock Information
  • Founded
  • FTFT N/A
  • IMNN 1982
  • Country
  • FTFT United States
  • IMNN United States
  • Employees
  • FTFT N/A
  • IMNN N/A
  • Industry
  • FTFT Business Services
  • IMNN Biotechnology: Pharmaceutical Preparations
  • Sector
  • FTFT Consumer Discretionary
  • IMNN Health Care
  • Exchange
  • FTFT Nasdaq
  • IMNN Nasdaq
  • Market Cap
  • FTFT 11.0M
  • IMNN 12.9M
  • IPO Year
  • FTFT N/A
  • IMNN 1985
  • Fundamental
  • Price
  • FTFT $2.36
  • IMNN $5.33
  • Analyst Decision
  • FTFT
  • IMNN Buy
  • Analyst Count
  • FTFT 0
  • IMNN 2
  • Target Price
  • FTFT N/A
  • IMNN $182.61
  • AVG Volume (30 Days)
  • FTFT 481.0K
  • IMNN 152.9K
  • Earning Date
  • FTFT 11-18-2025
  • IMNN 11-06-2025
  • Dividend Yield
  • FTFT N/A
  • IMNN N/A
  • EPS Growth
  • FTFT N/A
  • IMNN N/A
  • EPS
  • FTFT N/A
  • IMNN N/A
  • Revenue
  • FTFT $2,368,206.00
  • IMNN N/A
  • Revenue This Year
  • FTFT N/A
  • IMNN N/A
  • Revenue Next Year
  • FTFT N/A
  • IMNN N/A
  • P/E Ratio
  • FTFT N/A
  • IMNN N/A
  • Revenue Growth
  • FTFT N/A
  • IMNN N/A
  • 52 Week Low
  • FTFT $1.01
  • IMNN $4.70
  • 52 Week High
  • FTFT $5.70
  • IMNN $41.22
  • Technical
  • Relative Strength Index (RSI)
  • FTFT 54.72
  • IMNN 47.96
  • Support Level
  • FTFT $2.10
  • IMNN $5.04
  • Resistance Level
  • FTFT $2.28
  • IMNN $5.55
  • Average True Range (ATR)
  • FTFT 0.17
  • IMNN 0.29
  • MACD
  • FTFT 0.01
  • IMNN 0.04
  • Stochastic Oscillator
  • FTFT 92.55
  • IMNN 70.94

About FTFT Future FinTech Group Inc.

Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

Share on Social Networks: